Clinical Trial Update: Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating nimotuzumab in combination with neoadjuvant chemotherapy for cervical cancer. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Biotech Pharmaceutical Co., Ltd. | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN